Cargando…
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy
Human endogenous retroviruses (HERVs) represent 8% of the human genome. HERV products may represent tumor antigens relevant for cancer immunotherapy. We developed a bioinformatic approach to identify shared CD8(+) T cell epitopes derived from cancer-associated HERVs in solid tumors. Six candidates a...
Autores principales: | Bonaventura, Paola, Alcazer, Vincent, Mutez, Virginie, Tonon, Laurie, Martin, Juliette, Chuvin, Nicolas, Michel, Emilie, Boulos, Rasha E., Estornes, Yann, Valladeau-Guilemond, Jenny, Viari, Alain, Wang, Qing, Caux, Christophe, Depil, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791462/ https://www.ncbi.nlm.nih.gov/pubmed/35080970 http://dx.doi.org/10.1126/sciadv.abj3671 |
Ejemplares similares
-
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
por: Alcazer, Vincent, et al.
Publicado: (2022) -
Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019) -
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023) -
Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers
por: Alcazer, Vincent, et al.
Publicado: (2020) -
Avidity-based biosensors for ubiquitylated PCNA reveal choreography of DNA damage bypass
por: Yakoub, George, et al.
Publicado: (2023)